title: Treatment of refractory testis cancer: salvage or savage chemotherapy?
authors.affiliation: Division of Solid Tumor Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263.
authors.forename: E G
authors.initials: EG
authors.lastname: Levine
authors.forename: D
authors.initials: D
authors.lastname: Raghavan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D011379:Prognosis; D013678:Technology, Pharmaceutical; D013736:Testicular Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents